Head-to-head · Cost-Efficiency Index
Mondae vs Pallas Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Mondae
Cost-first shoppers who want a low all-in price with no membership attached and will count 13 billing cycles a year.
Visit MondaePallas Health
Shoppers comfortable paying a quarter at a time who want the whole cost stated before signup, and who are not looking for a month-to-month exit.
Visit Pallas HealthThe verdict
Mondae takes it, leading the Cost-Efficiency Index 79 to 74. Mondae charges $87 for compounded semaglutide and $126 for tirzepatide every 28 days, with the medication, the supplies, unlimited clinician messaging and shipping inside the figure and no consultation or membership fee. Pallas Health still earns a C — Shoppers comfortable paying a quarter at a time who want the whole cost stated before signup, and who are not looking for a month-to-month exit.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Mondae.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Mondae | Pallas Health |
|---|---|---|
| Cost-Efficiency Index | 79/100 | 74/100 |
| Semaglutide / mo | $87 every 28 days month-to-month (13 charges a year; the advertised $75 is the three-month prepay) | $199/mo average — Pallas's own figure for $597 billed every 12 weeks, its only cadence; $139 covers the first 4 weeks |
| Tirzepatide / mo | $126 every 28 days month-to-month (the advertised $124 is the three-month prepay) | $299/mo average — Pallas's own figure for $897 billed every 12 weeks, its only cadence; $179 covers the first 4 weeks |
| Semaglutide / yr (modeled) | $1,044 | $2,388 |
| Tirzepatide / yr (modeled) | $1,512 | $3,588 |
| Coverage | All 50 states | Most states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #35 | #42 |
Mondae
79/100Where the value is
- A low all-in figure on both molecules, with the medication, the injection supplies, unlimited clinician messaging and discreet shipping all inside it
- No membership fee and no consultation fee are charged on top of the medication price
- The three-month rate for each molecule is shown by a control on the same page, so the commitment and the monthly rate can be compared directly
The tradeoffs
- "From $75/mo" and "From $124/mo" on the homepage are the three-month prepay rates; the month-to-month rates are $87 and $126
- Billing is every 28 days rather than monthly, so a year costs 13 charges rather than 12
Pallas Health
74/100Where the value is
- Both molecules are priced publicly, with the charged block stated rather than only a monthly average
- A genuinely reduced first cycle — $139 semaglutide and $179 tirzepatide for the first four weeks
- Runs a Spanish-language lander as well as the English site, which most of this field does not
The tradeoffs
- There is no monthly rung. The only cadence is a 12-week block paid up front — $597 or $897 — so the advertised 'per month' figure is arithmetic rather than a payment anyone makes
- A 12-week cycle is 4.33 charges a year, not 4, so a year costs more than four times the block
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.